-DOCSTART- -X- O
The -X- _ O
common -X- _ B-Patient
cold -X- _ I-Patient
is -X- _ O
the -X- _ O
most -X- _ O
frequent -X- _ O
, -X- _ O
although -X- _ O
generally -X- _ O
mild -X- _ O
, -X- _ O
human -X- _ O
disease. -X- _ O
Human -X- _ O
Rhinoviruses -X- _ O
are -X- _ O
the -X- _ O
prevalent -X- _ O
causative -X- _ O
agents -X- _ O
, -X- _ O
but -X- _ O
other -X- _ O
viruses -X- _ O
are -X- _ O
also -X- _ O
implicated. -X- _ O
Being -X- _ O
so -X- _ O
common -X- _ O
, -X- _ O
viral -X- _ O
colds -X- _ O
, -X- _ O
have -X- _ O
significant -X- _ O
implications -X- _ O
on -X- _ O
public -X- _ O
health -X- _ O
and -X- _ O
quality -X- _ O
of -X- _ O
life -X- _ O
, -X- _ O
but -X- _ O
may -X- _ O
also -X- _ O
be -X- _ O
life-threatening -X- _ O
for -X- _ O
vulnerable -X- _ O
groups -X- _ O
of -X- _ O
patients. -X- _ O
Specific -X- _ O
diagnosis -X- _ O
and -X- _ O
treatment -X- _ O
of -X- _ O
the -X- _ O
common -X- _ B-Patient
cold -X- _ I-Patient
still -X- _ O
remain -X- _ O
unmet -X- _ O
needs. -X- _ O
Molecular -X- _ O
diagnostic -X- _ O
techniques -X- _ O
allow -X- _ O
specific -X- _ O
detection -X- _ O
of -X- _ O
known -X- _ O
pathogens -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
the -X- _ O
identification -X- _ O
of -X- _ O
newly -X- _ O
emerging -X- _ O
viruses. -X- _ O
Although -X- _ O
a -X- _ O
number -X- _ O
of -X- _ O
medications -X- _ B-Intervention
or -X- _ I-Intervention
natural -X- _ I-Intervention
treatments -X- _ I-Intervention
have -X- _ O
been -X- _ O
shown -X- _ O
to -X- _ O
have -X- _ O
some -X- _ O
effect -X- _ O
, -X- _ O
either -X- _ O
on -X- _ O
the -X- _ O
number -X- _ O
or -X- _ O
on -X- _ O
the -X- _ O
severity -X- _ O
of -X- _ O
common -X- _ O
colds -X- _ O
, -X- _ O
no -X- _ B-Outcome
single -X- _ I-Outcome
agent -X- _ I-Outcome
is -X- _ I-Outcome
considerably -X- _ I-Outcome
effective. -X- _ I-Outcome
Virus-specific -X- _ O
management -X- _ O
remains -X- _ O
in -X- _ O
most -X- _ O
cases -X- _ O
a -X- _ O
challenging -X- _ O
potential -X- _ O
as -X- _ O
many -X- _ O
factors -X- _ O
have -X- _ O
to -X- _ O
be -X- _ O
taken -X- _ O
into -X- _ O
account -X- _ O
, -X- _ O
including -X- _ O
the -X- _ O
diversity -X- _ O
of -X- _ O
the -X- _ O
viral -X- _ O
genomes -X- _ O
, -X- _ O
the -X- _ O
heterogeneity -X- _ O
of -X- _ O
affected -X- _ O
individuals -X- _ O
, -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
the -X- _ O
complexity -X- _ O
of -X- _ O
this -X- _ O
long -X- _ O
standing -X- _ O
host-virus -X- _ O
relationship -X- _ O
. -X- _ O

